Bisphosphonate-related osteonecrosis of the jaws: Study of the staging system in a series of clinical cases

Oral Oncology

Volumn 48, Issue 8, 2012, Pages 753-757

  Bagan, Jose V ^a   Hens Aumente, Elena ^b   Leopoldo Rodado, Manuel ^b   Poveda Roda, Rafael ^b   Bagan, Leticia ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Bisphosphonate; BRONJ; Dental; Jawbone

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER STAGING; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE FRACTURE; MAXILLARY SINUS; OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84864416865     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.02.009     Document Type: Article

References (31)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 9 2003 1115 1117 (Pubitemid 37064711)
2. J.V. Bagan, J. Murillo, Y. Jimenez, R. Poveda, M.A. Milian, and J.M. Sanchis Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases J Oral Pathol Med 34 2 2005 120 123
3. J.V. Bagan, Y. Jimenez, J. Murillo, S. Hernandez, R. Poveda, and J.M. Sanchis Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases Oral Oncol 42 3 2006 327 329 (Pubitemid 43246766)
4. S.L. Ruggiero, J. Fantasia, and E. Carlson Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 4 2006 433 441 [Epub 2006 Jul 31] (Pubitemid 44403162)
5. T. Boonyapakorn, I. Schirmer, P.A. Reichart, I. Sturm, and G. Massenkeil Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies Oral Oncol 44 9 2008 857 869
6. S. Fedele, S.R. Porter, F. D'Aiuto, S. Aljohani, P. Vescovi, and M. Manfredi Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series Am J Med 123 11 2010 Nov 1060 1064
7. S. Otto, M.H. Abu-Id, S. Fedele, P.H. Warnke, S.T. Becker, and A. Kolk Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence-a multi-centre study J Craniomaxillofac Surg 39 4 2011 Jun 272 277
8. Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S. Early Surgical Laser-Assisted Management of Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ): a Retrospective Analysis of 101 Treated Sites with Long-Term Follow-Up. Photomed Laser Surg 2011 [Epub ahead of print].
9. J. Baillargeon, Y.F. Kuo, Y.L. Lin, G.S. Wilkinson, and J.S. Goodwin Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates Ann Pharmacother 45 10 2011 1199 1206
10. N. Ngamphaiboon, J.L. Frustino, E.B. Kossoff, M.A. Sullivan, and T.L. O'Connor Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab Clin Breast Cancer 11 4 2011 Aug 252 257
11. O. Nicolatou-Galitis, E. Papadopoulou, T. Sarri, P. Boziari, A. Karayianni, and M.C. Kyrtsonis Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2 2011 195 202
12. F. Francini, A. Pascucci, E. Francini, S.T. Miano, G. Bargagli, and G. Ruggiero Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab J Am Dent Assoc. 142 5 2011 506 513
13. D.H. Henry, L. Costa, F. Goldwasser, V. Hirsh, V. Hungria, and J. Prausova Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma J Clin Oncol 29 9 2011 1125 1132
14. M. Manfredi, E. Merigo, R. Guidotti, M. Meleti, and P. Vescovi Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis Int J Oral Maxillofac Surg 40 3 2011 277 284
15. D.H. Solomon, L. Rekedal, and S.M. Cadarette Osteoporosis treatments and adverse events Curr Opin Rheumatol 21 4 2009 363 368
16. T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, and S. Soen Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 4 2010 365 383
17. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009; 67(5 Suppl):2-12.
18. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, and R.E. Marx Task force on bisphosphonate-related osteonecrosis of the jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update Aust Endod J 35 3 2009 119 130
19. S. Ruggiero, J. Gralow, R.E. Marx, A.O. Hoff, M.M. Schubert, and J.M. Huryn Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer J Oncol Pract 2 1 2006 7 14
20. S.A. Almazrooa, and S.B. Woo Bisphosphonate and nonbisphosphonate- associated osteonecrosis of the jaw: a review J Am Dent Assoc 140 7 2009 864 875
21. R. Sacco, G. Sacco, A. Acocella, S. Sale, N. Sacco, and E. Baldoni A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis J Appl Oral Sci 19 4 2011 293 300
22. P. Vescovi, G. Campisi, V. Fusco, G. Mergoni, M. Manfredi, and E. Merigo Surgery-triggered and non surgery-triggered bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study Oral Oncol 47 3 2011 191 194
23. A. Kyrgidis, G. Koloutsos, and K. Vahtsevanos Treatment protocols of bisphosphonate-related osteonecrosis of the jaws Head Neck 31 8 2009 1112 1113 [author reply 1113-4]
24. S.L. Ruggiero, and B. Mehrotra Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management Annu Rev Med. 60 2009 85 96
25. J.W. Hellstein, R.A. Adler, B. Edwards, P.L. Jacobsen, J.R. Kalmar, and S. Koka American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs J Am Dent Assoc 142 11 2011 1243 1251
26. G. Colella, G. Campisi, and V. Fusco American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition J Oral Maxillofac Surg 67 12 2009 2698 2699
27. L.A. Assael Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies J Oral Maxillofac Surg 67 5 Suppl 2009 35 43
28. T.S. Lazarovici, R. Yahalom, S. Taicher, S. Elad, I. Hardan, and N. Yarom Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 4 2009 850 855
29. L. Junquera, and L. Gallego Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 66 7 2008 1516 1517 (Pubitemid 351822447)
30. R.E. McMahon, J.E. Bouquot, C.J. Glueck, J.A. Griep, W.R. Adams, and K.J. Spolnik Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease J Oral Maxillofac Surg 65 9 2007 1899 1900 (Pubitemid 47268616)
31. H. Mawardi, N. Treister, P. Richardson, K. Anderson, N. Munshi, and R.A. Faiella Sinus tracts-an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67 3 2009 593 601